Abstract:Chronic obstructive pulmonary disease (COPD) is a heterogeneous inflammatory disease and eosinophils (EOS) participate in inflammation process. Acute exacerbation of COPD (AECOPD) is an inevitable trend in the development of the disease and has attracted widespread attention. In the present study, 108 hospitalized patients with AECOPD were collected and the levels of interleukin-13 and eosinophil cationic protein in the serum and sputum were measured to explore their clinical value in eosinophilic AECOPD patients. The patients were divided into an eosinophilic group (52 cases, 48.15%) and a noneosinophilic group (56 cases, 51.85%). The eosinophilic group had fewer acute exacerbations in the past year, shorter average hospitalization days, lower respiratory failure rate, mechanical ventilation utilization rate, and lower CAT and mMRC scores ( P < 0.05). The levels of interleukin-13 and eosinophil cationic protein in sputum in the eosinophilic group were higher than those in the noneosinophilic group ( P 0.05). The receiver operating characteristic (ROC) curves of sputum interleukin-13 and eosinophil cationic protein predicting peripheral blood EOS% ≥2% of AECOPD patients were statistically significant ( P < 0.05). The noneosinophilic group had a higher rate of rehospitalization due to acute exacerbation during the one-year follow-up, and there was no significant difference in mortality between the two groups. The results show that eosinophils in peripheral blood are a simple, convenient, and inexpensive index for assessing the condition and prognosis of AECOPD patients. Interleukin-13 and eosinophil cationic protein are involved in the pathogenesis of eosinophilic AECOPD and may be the new targeted anti-inflammatory therapies in the future. Impact statement Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is an inevitable trend in the development of the disease and eosinophils (EOS) participate in inflammation process. It is important to explore some relatively simple biomarkers in AECOPD which are useful to recognize the disease. In the present study, 108 hospitalized patients with AECOPD were collected and the levels of IL-13 and ECP in the serum and sputum were measured. The levels of IL-13 and ECP in sputum in the eosinophilic group were higher than those in the noneosinophilic group. Moreover, the noneosinophilic group had a higher rate of rehospitalization due to acute exacerbation during the one-year follow-up. The results show that eosinophils in peripheral blood are a simple, convenient, and inexpensive index for assessing the condition and prognosis of AECOPD patients. IL-13 and ECP are involved in the pathogenesis of eosinophilic AECOPD and may be the new targeted anti-inflammatory therapies.

ILC2s Induce Adaptive Th2-Type Immunity in Acute Exacerbation of Chronic Obstructive Pulmonary Disease

ILC2 Cells Promote Th2 Cell Differentiation in AECOPD Through Activated Notch-GATA3 Signaling Pathway

Eosinopenia and ILC2 Immune Dysfunction in COPD Exacerbation is Associated to the Upregulation of ILC3/IL-22 Axis

Type 2 Innate Lymphoid Cells Participate in IL-33-stimulated Th2-associated Immune Response in Chronic Obstructive Pulmonary Disease

Expression of Epithelial Alarmin Receptor on Innate Lymphoid Cells Type 2 in Eosinophilic Chronic Obstructive Pulmonary Disease

The role of Th1/Th2 cytokines played in regulation of specific CD4 + Th1 cell conversion and activation during inflammatory reaction of chronic obstructive pulmonary disease

Clinical value of IL-13 and ECP in the serum and sputum of eosinophilic AECOPD patients

ILC2s Induce Adaptive Th2-type Immunity in Different Stages of Tuberculosis Through the Notch-GATA3 Pathway.

IL-13+ Type 2 Innate Lymphoid Cells Correlate with Asthma Control Status and Treatment Response.

Interleukin-2/anti-interleukin-2 complex attenuates inflammation in a mouse COPD model by expanding CD4+ CD25+ Foxp3+ regulatory T cells

Influenza a Virus Triggers Acute Exacerbation of Chronic Obstructive Pulmonary Disease by Increasing Proinflammatory Cytokines Secretion Via NLRP3 Inflammasome Activation

Peripheral Pathological ILC2: an Inflammatory Indicator for the Assessment of Asthma Control in Clinics

An observation of Th1/Th2 unbalance in patients with chronic obstructive pulmonary disease

Research Progress on Type Ⅱ Innate Lymphoid Cells in Chronic Obstructive Pulmonary Disease

Pathological ILC2 in Peripheral Blood Acts As an Indicator for the Assessment of Asthma Control in Clinics

Protective Role of Ilc2 in Sepsis-Induced Acute Lung Injury

Role of CD4 + T and CD8 + T Lymphocytes-Mediated Cellular Immunity in Pathogenesis of Chronic Obstructive Pulmonary Disease

Eosinophils promote effector functions of lung group 2 innate lymphoid cells in allergic airway inflammation in mice

Th1/Th17 Cytokine Profiles Are Associated With Disease Severity And Exacerbation Frequency In Copd Patients

Analysis of the total serum IgE levels in patients with acute exacerbations chronic obstructive pulmonary disease: A retrospective study

Association between peripheral blood WBCs C3aR mRNA level and plasma C3a, C3aR, IL-1β concentrations and acute exacerbation of chronic obstructive pulmonary disease